ATS GUIDELINES Bundle

Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1513495

Contents of this Issue

Navigation

Page 4 of 5

Certainty of Evidence Evidence Quality Definition High ⊕⊕⊕⊕ High confidence that the estimated effect is close to the true effect. Moderate ⊕⊕⊕ Moderate confidence that the estimated effect is close to the true effect, but with a chance that the true effect is considerably different. Low ⊕⊕ Low confidence in the estimated effect. Higher likelihood that the true effect is considerably different from the estimated effect. Very Low ⊕ Very low confidence in the estimated effect. High likelihood that the true effect is considerably different from the estimated effect. Implications of Clinical Guideline Recommendations Stakeholder Strong Recommendation Conditional Recommendation Patient Most individuals in this situation would want the recommended course of action, and only a small proportion would not. The majority of individuals in this situation would want the suggested course of action, but some would not. Clinician Most individuals should receive the intervention. Adherence to this recommendation according to the guideline could be used as a quality criterion or performance indicator. Formal decision aids are not likely to be needed to help individuals make decisions consistent with their values and preferences. Recognize that different choices will be appropriate for individual patients and that you must help each patient arrive at a management decision consistent with their values and preferences. Decision aids may be useful in helping individuals to make decisions consistent with their values and preferences. Policy-maker The recommendation can be adopted as policy in most situations. Policy making will require substantial debate and involvement of various stakeholders.

Articles in this issue

view archives of ATS GUIDELINES Bundle - Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease